SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-073344
Filing Date
2022-11-17
Accepted
2022-11-17 10:24:53
Documents
14
Period of Report
2022-11-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168866-8k_inmedpharma.htm   iXBRL 8-K 29249
2 NEWS RELEASE, DATED NOVEMBER 16, 2022 ea168866ex99-1_inmedpharma.htm EX-99.1 18596
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-22-073344.txt   234928

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20221116.xsd EX-101.SCH 3233
5 XBRL LABEL FILE inm-20221116_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inm-20221116_pre.xml EX-101.PRE 22364
8 EXTRACTED XBRL INSTANCE DOCUMENT ea168866-8k_inmedpharma_htm.xml XML 3743
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221397054
SIC: 2834 Pharmaceutical Preparations